C-MER Medical Holdings (3309) Stock Overview
An investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
3309 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
C-MER Medical Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.97 |
| 52 Week High | HK$3.04 |
| 52 Week Low | HK$1.33 |
| Beta | 0.64 |
| 1 Month Change | 4.23% |
| 3 Month Change | 11.30% |
| 1 Year Change | -4.37% |
| 3 Year Change | -47.88% |
| 5 Year Change | -69.31% |
| Change since IPO | -61.45% |
Recent News & Updates
Recent updates
C-MER Medical Holdings Limited (HKG:3309) Might Not Be As Mispriced As It Looks After Plunging 26%
Apr 08
Returns On Capital Signal Tricky Times Ahead For C-MER Medical Holdings (HKG:3309)
Nov 13Is C-MER Medical Holdings (HKG:3309) A Risky Investment?
Oct 18Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%
Sep 04Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being
May 21C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point
Apr 29C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk
Feb 02C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively
Jan 17A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)
Apr 24Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal
Dec 04Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?
Sep 22Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year
Dec 07Shareholder Returns
| 3309 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 2.1% | -0.2% | 2.6% |
| 1Y | -4.4% | 7.8% | 52.8% |
Return vs Industry: 3309 underperformed the Hong Kong Healthcare industry which returned 7.8% over the past year.
Return vs Market: 3309 underperformed the Hong Kong Market which returned 52.8% over the past year.
Price Volatility
| 3309 volatility | |
|---|---|
| 3309 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 3309 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 3309's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 2,041 | Xiaoting Li | www.cmermedical.com |
C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, Mainland China Dental Business, and Mainland China other business. The company provides oncology, medical aesthetics, general practice, ophthalmic, dental, and other medical services; cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services; and medical consumables.
C-MER Medical Holdings Limited Fundamentals Summary
| 3309 fundamental statistics | |
|---|---|
| Market cap | HK$2.35b |
| Earnings (TTM) | -HK$115.98m |
| Revenue (TTM) | HK$1.93b |
Is 3309 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3309 income statement (TTM) | |
|---|---|
| Revenue | HK$1.93b |
| Cost of Revenue | HK$1.33b |
| Gross Profit | HK$601.68m |
| Other Expenses | HK$717.66m |
| Earnings | -HK$115.98m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.097 |
| Gross Margin | 31.09% |
| Net Profit Margin | -5.99% |
| Debt/Equity Ratio | 2.3% |
How did 3309 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/15 16:06 |
| End of Day Share Price | 2025/09/15 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
C-MER Medical Holdings Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fangqi Dai | China Merchants Securities (HK) Co., Ltd |
| Wei Zheng | Tianfeng Securities Brokerage Co., Ltd |